Ogen

--If you miss a dose...

Take the forgotten dose as soon as you remember. If it is almost time for the next dose, skip the one you missed and go back to your regular schedule. Never try to "catch up" by doubling the dose.

--Storage instructions...

Store at room temperature.

Ogen side effects

Side effects cannot be anticipated. If any develop or change in intensity, notify your doctor as soon as possible. Only your doctor can determine if it is safe for you to continue taking estrogen.

• Side effects may include:
  Abdominal cramps, bloating, breakthrough bleeding, breast enlargement, breast tenderness and secretions, change in amount of cervical secretion, changes in sex drive, changes in vaginal bleeding patterns, chorea (irregular, rapid, jerky movements, usually affecting the face and limbs), depression, dizziness, enlargement of benign tumors (fibroids), excessive hairiness, fluid retention, hair loss, headache, inability to use contact lenses, menstrual changes, migraine, nausea, reduced ability to tolerate carbohydrates, spotting, spotty darkening of the skin, especially around the face, skin eruptions (especially on the legs and arms) with bleeding, skin irritation, skin redness and scaling, vaginal yeast infection, vision problems, vomiting, weight gain or loss, yellow eyes and skin

Why should Ogen not be prescribed?

Estrogens should not be used if you know or suspect you have breast cancer or other cancers promoted by estrogen. Do not use estrogen if you are pregnant or think you may be pregnant. Also avoid estrogen if you have abnormal, undiagnosed genital bleeding, or if you have blood clots or a blood clotting disorder or a history of blood clotting disorders associated with previous estrogen use.

Ogen Vaginal Cream should not be used if you are sensitive to or have ever had an allergic reaction to any of its components.

Special warnings about Ogen

The risk of cancer of the uterus increases when estrogen is used for a long time or taken in large doses. There also may be increased risk of breast cancer in women who take estrogen for an extended period of time.